Regeneron and Sanofi’s Dupixent FDA-approved for eosinophilic esophagitis May 23, 2022 Auto Bot Markets & Regulations 0 The approval is the first that the Food and Drug Administration has granted for a drug intended to treat eosinophilic esophagitis, a chronic immune disorder.